Overview of interleukin-18: More than an interferon-γ inducing factor

Journal of Leukocyte Biology

Volumn 63, Issue 6, 1998, Pages 658-664

  Dinarello, Charles A ^a   Novick, Daniela ^b   Puren, Adrian J ^a   Fantuzzi, Giamila ^a   Shapiro, Leland ^a   Mühl, Heiko ^a   Yoon, Do Young ^a   Reznikov, Leonid L ^a   Kim, Soo Hyun ^b   Rubinstein, Menachem ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Interleukin 1 ; Nuclear factor B

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN RECEPTOR;

CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; KERATINOCYTE; LIGAND BINDING; LIVER INJURY; PRECURSOR; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; T LYMPHOCYTE ACTIVATION; TUMOR SUPPRESSOR GENE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031749136     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.63.6.658     Document Type: Review

References (62)

1. Nakamura, K., Okamura, H., Wada, M., Nagata, K., Tamura, T. (1989) Endotoxin-induced serum factor that stimulates gamma inteferon production. Infect. Immun. 57, 590-595.
2. Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tammoto, T., Torigoe, K., Fujii, M., Ikeda, M., Fukuda, S., Kurimoto, M. (1996) Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26, 1647-1651.
3. Kohno, K., Kataoka, J., Ohtsuki, T., Suemoto, Y., Okamoto, I., Usui, M., Ikeda, M., Kurimoto, M. (1997) IFN-γ-inducing factor (IGIF) is a co-stimulatory factor on the activation of Th1 but no, Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158, 1541-1550.
4. Yoshimoto, T., Okamura, H., Tagawa, Y.-I., Iwakura, Y., Nakanishi, K. (1997) Interleukin-18 together with interleukin-12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc. Natl. Acad. Sci. USA 94, 3948-3953.
5. Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, F., Konishi, K., Mcallef, M., Fujii, M., Torigoe, K., Tanimoto, T., Fukuda, S., Ikeda, M., Okamura, H., Kurimoto, M. (1996) Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156, 4274-4279.
6. Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akita, K., Namba, M., Tanabe, F., Komshi, K., Fukuda, S., Kunmoto, M. (1995) Cloning of a new cytokine that induces interferon-γ. Nature 378, 88-91.
7. Fantuzzi, G., Puren, A. J., Harding, M. W., Livingston, D. J., Dinarello, C. A. (1998) IL-18 regulation of IFN-γ production and cell proliferation as revealed in interleukin-1β converting enzyme-deficient mice. Blood, 91, 2118-2125.
8. + human blood mononuclear cells. J. Clin. Invest., 101, 711-721.
9. Matsimoto, S., Tsuji-Takayama, K., Aizawa, Y., Koide, K., Takeuchi, M., Ohta, T., Kurimoto, M. (1997) Interleukin-18 activates NFκB in murine T helper type I cells. Biochem. Biophys. Res. Commun. 234, 454-457.
10. Torigoe, K., Ushio, S., Okura, T., Kobayashi, S., Taniai, M., Kunikate, T., Murakami, T., Sanou, O., Kojima, H., Fuji, M., Ohta, T., Ikeda, M., Ikegami, H., Kurimoto, M. (1997) Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272, 25737-25742.
11. Tsutsui, H., Nakanishi, K., Matsui, K., Higashino, K., Okamura, H., Miyazawa, Y., Kaneda, K. (1996) IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157, 3967-3973.
12. Dao, T., Ohashi, K., Kayano, T., Kurimoto, M., Okamura, H. (1997) Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper cells. Cell. Immunol. 173, 230-235.
13. Ohtsuki, T., Micallef, M. J., Kohno, K., Tanimoto, T., Ikeda, M., Kurimoto, M. (1997) Interleukin-18β enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res. 17, 3253-3258.
14. Shapiro, L., Puren, A. J., Razeghi, P., Heidenreich, K. A., Meintzer, M. K., Dinarello, C. A. (1997) IL-18 induces HIV-1 production in U1 cells with dependence on tumor necrosis factor, IL-6 and the p38 mitogen activated protein (MAP) kinase. Cytokine 9, 893 (abstract).
15. Muhl, H., Shapiro, L., Dinarello, C. A. (1997) The nitric oxide synthase inhibitor L-NMMA is a potent inhibitor of IL-18 induced expression of HIV-1 in the chronically infected macrophage U1 cell. Cytokine 9, 947 (abstract).
16. Rothe, H., Jenkins, N. A., Copeland, N. G., Kolb, H. (1997) Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J. Clin. Invest. 99, 469-474.
17. Sarvetnick, N. (1997) IFN-γ, IGIF and IDDM. J. Clin. Invest. 99, 371-372.
18. Stoll, S., Mueller, G., Kurimoto, M., Saloga, J., Tanimoto, T., Yamauchi, H., Okamura, H., Knop, J., Enk, A. H. (1997) Production of IL-18 (IFN-γ-inducing factor) messenger RNA and functional protein by murine keratinocytes. J. Immunol. 159, 298-302.
19. Taniguchi, M., Nagaoka, K., Kunikata, T., Kayano, T., Tamauchi, H., Nakamura, S., Ikeda, M., Orita, K., Kurimoto, M. (1997) Characterization of anti-human interleukin-18 (IL-18)/interferon inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 ELISA. J. Immunol. Meth. 206, 107-113.
20. Conti, B., Jeong, J. W., Tinti, C., Son, J. H., Joh, T. H. (1997) Induction of IFN-γ-inducing factor in the adrenal cortex. J. Biol. Chem. 272, 2035-2037.
21. Nakamura, K., Okamura, H., Nagata, K., Komatsu, T., Tamura, T. (1993) Purification of a factor which provides a costimulatory signal for gamma Interferon production. Infect. Immun. 61, 64-70.
22. Okamura, H., Nagata, K., Komatsu, T., Tanimoto, T., Nukata, Y., Tanabe, F., Akita, K., Torigoe, K., Okura, T., Fukuda, S., Kurimoto, M. (1995) A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 63, 3966-3972.
23. Heremans, H., Van Damme, J., Dillen, C., Dikman, R., Billiau, A. (1990) Interferon-γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock in mice. J. Exp. Med. 171, 1853-1861.
24. Car, B. D., Eng, V. M., Schnãyder, B., Ozmen, L., Huang, S., Gallay, P., Heumann, D., Aguet, M., Ryffel, B. (1994) Interferon γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179, 1437-1444.
25. Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., O'Garra, A. (1997) IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFKB. Immunity 7, 571-581.
26. Hunter, C. A., Timans, J., Pisacane, P., Menon, S., Cai, G., Walker, W., Aste-Amezaga, M., Chizzonite, R., Bazan, J. F., Kastelein, R. A. (1997) Comparison of the effects of interleukin-1α, interleukin-1β and interferon-γ inducing factor on the production of interferon-γ by natural killer. Eur. J. Immunol. 27, 2787-2792.
27. Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter, A., Quintal, L., Sekut, L., Talanian, R., Paskind, M., Wong, W., Kamen, R., Tracey, D., Allen, H. (1997) Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386, 619-623.
28. Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., Kurimoto, M., Tanimoto, T., Flavell, R. A., Sato, V., Harding, M. W., Livingston, D. L., Su, M. S.-S. (1997) Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275, 206-209.
29. Bazan, J. F., Timans, J. C., Kaselein, R. A. (1996) A newly defined interleukin-1? Nature 379, 591.
30. Udagawa, N., Horwood, N. J., Elliot, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Gillespie, M. T. (1997) Interleukin-18 is produced by osteoblasts and acts via granulocyte macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoclast formation. J. Exp. Med. 185, 1005-1012.
31. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., Yuan, J. (1996) Human ICE/CED-3 protease nomenclature. Cell 87, 123.
32. Gu, Y., Wu, J., Faucheu, C., Lalanne, J.-L., Diu, A., Livingston, D. L., Su, M. S.-S. (1995) Interleukin-1β converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J. 14, 1923-1931.
33. Akita, K., Ohtsuki, T., Nukada, Y., Tanimoto, T., Namba, M., Okura, T., Takakura-Yamamoto, R., Torigoe, K., Gu, Y., Su, M. S.-S., Fuji, M., Satoh-Itoh, M., Yamamoto, K., Kohno, K., Ikeda, M., Kurimoto, M. (1997) Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin-18 in monocytic THR.1 cells. J. Biol. Chem. 272, 26595-26606.
34. Tatsuta, T., Cheng, J., Mountz, J. D. (1997) Intracellular IL-1β is an inhibitor of Fas-mediated apoptosis. J. Immunol 157, 3949-3957.
35. Ahn, H.-J., Maruo, S., Tomura, M., Mu, J., Hamaoka, T., Nakanishi, K., Clark, S., Kurimoto, M., Okamura, H., Fujiwara, H. (1997) A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ J. Immunol. 159, 2125-2131.
36. Parnet, P., Garka, K. E., Bonnert, T. P., Dower, S. K., Sims, J. E. (1996) IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem. 271, 3967-3970.
37. Croston, G. E., Cao, Z., Goeddel, D. V. (1995) NFKB activation by interleukin-1 requires an IL-1 receptor-associated protein kinase activity. J. Biol. Chem. 270, 16514-16517.
38. Tsutsui, H., Matsui, K., Kawada, Y., Hyodo, N., Hyashi, H., Okamura, H., Higashino, K., Nakanishi, K. (1997) Interleukin-18 accounts for both tumor necrosis factor-α and FAS ligand mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. Cytokine 9, 964 (abstract).
39. Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C. A., Nerup, J. (1987) Potentiation of IL-1 mediated B-cell killing by TNF. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J. Immunol. 139, 4077-4082.
40. Punkel, C., Baquerizo, H., Rabinovitch, A. (1988) Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of IFN-γ, TNF, LT and interleukin-1. Diabetes 37, 133-136.
41. Rothe, H., Hibiono, T., Itoh, Y., Kolb, H., Martin, S. (1997) Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulins in NOD mice. Autoimmun. 10, 251-256.
42. Froyen, G., Billiau, F. (1997) Potential therapeutic use of antibodies directed towards HuIFN-γ. Biother. 10, 49-57.
43. Ferber, I. A., Brocke, S., Cariel, T.-E., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., Fathman, C. G. (1996) Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5-7.
44. Kobayashi, Y., Appella, E., Yamada, M., Copeland, T. D., Oppenheim, J. J., Matsushima, K. (1988) Phosphorylation of intracellular precursors of human IL-1. J. Immunol. 140, 2279-2287.
45. Micallef, M. J., Tanimoto, T., Kohno, K., Ikeda, M., Kurimoto, M. (1997) Interleukin-18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res. 57, 4557-4563.
46. Lotze, M. T., Osaki, T., Peron, J.-M., Shurin, B., Baar, J., Tahra, H. (1997) Cytokines which induce interferon-γ, IL-2, IL-12 and IL-18: regulation of tumor immunity. J. Leukoc. Biol. 25 (abstract).
47. Kawakami, K., Qureshi, M. H., Zhang, T., Okamura, H., Kurimoto, M., Saito, A. (1997) IL-18 protects mice against pulmonary and disseminated infection with Cryptococcal neoformans by inducing IFN-γ production. J. Immunol. 159, 5528-5534.
48. Van't Wout, J. W., Van Der Meer, J. W. M., Barza, M., Dinarello, C. A. (1988) Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1. Eur. J. Immunol. 18, 1143-1146.
49. Nakanishi, K., Yoshimoto, T., Ohkushu, K., Takeda, K., Kashiwamura, S.-I., Torigoe, K., Kurimoto, N., Akira, S., Okamura, H. (1997) Demonstration of up-regulated IL-18 receptor expression on IL-12 stimulated T-cells. Cytokine 9, 947 (abstract).
50. Sims, J. E., Gayle, M. A., Slack, J. L., Alderson, M. R., Bird, T. A., Giri, J. G., Colotta, F., Re, F., Mantovani, A., Shanebeck, K., Grabstein, K. H., Dower, S. K. (1993) Interleukin-1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90, 6155-6159.
51. Greenfeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A., Ju, G. (1995) Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270, 13757-13765.
52. Novick, D., Engelmann, H., Wallach, D., Rubinstein, M. (1989) Soluble cytokine receptors are present in normal human unne. J. Exp. Med. 170, 1409-1414.
53. Engelmann, H., Novick, D., Wallach, D. (1990) Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265, 1531-1536.
54. Novick, D., Cohen, B., Rubinstein, M. (1994) The human interferon α/β receptor: characterization and molecular cloning. Cell 77, 391-400.
55. Novick, D., Engelmann, H., Wallach, D., Leitner, O., Revel, M., Rubinstein, M. (1990) Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography. J. Chromat. 510, 331-337.
56. Novick, D., Dinarello, C. A., Rubinstein, M. (1997) Soluble IL-18 receptor in human urine: characterization and purification. Cytokine 9, 963 (abstract).
57. Dinarello, C. A. (1996) Biological basis for interleukin-1 in disease. Blood 87, 2095-2147.
58. Bresnihan, B., Lookabaugh, J., Witt, K., Musikic, P. (1996) Treatment with recombinant human interleukin-1 receptor antagonist in rheumatoid arthritis: results of a randomized, double-blind, placebo-controlled multicenter trial. Arthrit. Rheumatol. 39, S73 (abstract).
59. Watt, I., Cobby, M. (1996) Recombinant human interleukin-1 receptor antagonist reduces the rate of joint erosion in rheumatoid arthritis. Arthrit. Rheumatol. 39, S123.
60. Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., Widmer, M. B., Blosch, C. M. (1997) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337, 141-147.
61. Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Long-Fox, A., Charles, P., Bijl, H., Woody, J. N. (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105-1110.
62. Van Dullemen, H. M., Van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N., Woody, J. (1995) Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterol. 109, 129-135.